|
|
regulation of mast cell activation
|
GO:0033003 |
21 |
0.997
|
|
|
|
metanephric glomerular visceral epithelial cell differentiation
|
GO:0072248 |
2 |
0.994
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.993
|
|
|
|
metanephric glomerular visceral epithelial cell development
|
GO:0072249 |
2 |
0.988
|
|
|
|
regulation of type iia hypersensitivity
|
GO:0001796 |
4 |
0.987
|
|
|
|
positive regulation of type iia hypersensitivity
|
GO:0001798 |
4 |
0.984
|
|
|
|
positive regulation of type iii hypersensitivity
|
GO:0001805 |
3 |
0.961
|
|
|
|
positive regulation of myeloid leukocyte mediated immunity
|
GO:0002888 |
14 |
0.958
|
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.933
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.921
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class i
|
GO:0042590 |
6 |
0.913
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.911
|
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.905
|
|
|
|
regulation of type iii hypersensitivity
|
GO:0001803 |
3 |
0.897
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.893
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.879
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.879
|
|
|
|
positive regulation of type ii hypersensitivity
|
GO:0002894 |
4 |
0.876
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.871
|
|
|
|
fc epsilon receptor signaling pathway
|
GO:0038095 |
3 |
0.862
|
|
|
|
metanephric glomerular epithelial cell differentiation
|
GO:0072312 |
2 |
0.862
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.842
|
|
|
|
regulation of type ii hypersensitivity
|
GO:0002892 |
4 |
0.838
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.823
|
|
|
|
regulation of mast cell activation involved in immune response
|
GO:0033006 |
17 |
0.820
|
|
|
|
mast cell mediated immunity
|
GO:0002448 |
20 |
0.790
|
|
|
|
detection of oxidative stress
|
GO:0070994 |
1 |
0.778
|
|
|
|
type iia hypersensitivity
|
GO:0001794 |
4 |
0.771
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.764
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.764
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.750
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.744
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.743
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.738
|
|
|
|
serotonin production involved in inflammatory response
|
GO:0002351 |
4 |
0.729
|
|
|
|
positive regulation of epithelial cell differentiation involved in kidney development
|
GO:2000698 |
2 |
0.715
|
|
|
|
serotonin secretion
|
GO:0001820 |
8 |
0.710
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.698
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.694
|
|
|
|
lysosome localization
|
GO:0032418 |
20 |
0.686
|
|
|
|
antigen processing and presentation of peptide antigen via mhc class i
|
GO:0002474 |
9 |
0.685
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.685
|
|
|
|
type iii hypersensitivity
|
GO:0001802 |
3 |
0.680
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.680
|
|
|
|
mast cell activation involved in immune response
|
GO:0002279 |
20 |
0.658
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.658
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.655
|
|
|
|
detection of peptidoglycan
|
GO:0032499 |
1 |
0.649
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
27 |
0.644
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.642
|
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.638
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.637
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.631
|
|
|
|
renal filtration cell differentiation
|
GO:0061318 |
10 |
0.624
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.622
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.621
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.610
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.609
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.606
|
|
|
|
regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010640 |
9 |
0.599
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.579
|
|
|
|
regulation of hypersensitivity
|
GO:0002883 |
10 |
0.574
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.571
|
|
|
|
neutrophil activation involved in immune response
|
GO:0002283 |
8 |
0.563
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.543
|
|
|
|
renal protein absorption
|
GO:0097017 |
1 |
0.541
|
|
|
|
fc receptor mediated stimulatory signaling pathway
|
GO:0002431 |
4 |
0.539
|
|
|
|
cerebellar granule cell differentiation
|
GO:0021707 |
9 |
0.521
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.520
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.519
|
|
|
|
antigen processing and presentation of exogenous peptide antigen
|
GO:0002478 |
21 |
0.515
|
|
|
|
regulation of type i hypersensitivity
|
GO:0001810 |
4 |
0.513
|
|
|
|
cell migration involved in metanephros development
|
GO:0035788 |
2 |
0.513
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.510
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.509
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.506
|
|
|
|
dendritic cell differentiation
|
GO:0097028 |
26 |
0.504
|
|
|
|
positive regulation of type i hypersensitivity
|
GO:0001812 |
3 |
0.502
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.480
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.475
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.475
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.467
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.455
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.445
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.443
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.435
|
|
|
|
type i hypersensitivity
|
GO:0016068 |
4 |
0.433
|
|
|
|
regulation of epithelial cell differentiation involved in kidney development
|
GO:2000696 |
10 |
0.431
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.430
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.425
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.424
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.418
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.409
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.407
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.402
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.396
|
|
|
|
negative regulation of hypersensitivity
|
GO:0002884 |
3 |
0.393
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.388
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.388
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.384
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.383
|
|
|
|
regulation of renal albumin absorption
|
GO:2000532 |
1 |
0.370
|
|
|
|
negative regulation of metanephric mesenchymal cell migration
|
GO:2000590 |
1 |
0.358
|
|
|
|
positive regulation of mast cell degranulation
|
GO:0043306 |
10 |
0.357
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.349
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.344
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.343
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.342
|
|
|
|
positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0045425 |
2 |
0.336
|
|
|
|
glomerular epithelial cell differentiation
|
GO:0072311 |
10 |
0.334
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.332
|
|
|
|
positive regulation of toll like receptor 9 signaling pathway
|
GO:0034165 |
2 |
0.331
|
|
|
|
positive regulation of glomerulus development
|
GO:0090193 |
5 |
0.331
|
|
|
|
glomerular epithelial cell development
|
GO:0072310 |
6 |
0.329
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.327
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.327
|
|
|
|
regulation of metanephric glomerular visceral epithelial cell development
|
GO:2000477 |
1 |
0.321
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.321
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
25 |
0.319
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.317
|
|
|
|
negative regulation of type i hypersensitivity
|
GO:0001811 |
1 |
0.315
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.313
|
|
|
|
positive regulation of muscle adaptation
|
GO:0014744 |
2 |
0.305
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.304
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.301
|
|
|
|
platelet degranulation
|
GO:0002576 |
6 |
0.300
|
|
|
|
cellular response to ammonium ion
|
GO:0071242 |
2 |
0.298
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.297
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.295
|
|
|
|
granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0042253 |
2 |
0.294
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.293
|
|
|
|
histamine production involved in inflammatory response
|
GO:0002349 |
1 |
0.292
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.290
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.286
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.286
|
|
|
|
positive regulation of camp dependent protein kinase activity
|
GO:2000481 |
3 |
0.285
|
|
|
|
neutrophil activation
|
GO:0042119 |
9 |
0.283
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.276
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.274
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
16 |
0.274
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.273
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.272
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.271
|
|
|
|
positive regulation of metanephric glomerular visceral epithelial cell development
|
GO:2000478 |
1 |
0.270
|
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
14 |
0.269
|
|
|
|
cerebellar granular layer formation
|
GO:0021684 |
9 |
0.266
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.261
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.260
|
|
|
|
serotonin secretion by platelet
|
GO:0002554 |
3 |
0.259
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.256
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.256
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.256
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.255
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.249
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.249
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.247
|
|
|
|
mast cell degranulation
|
GO:0043303 |
19 |
0.243
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.243
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.241
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.240
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.240
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.240
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.237
|
|
|
|
positive regulation of leukocyte degranulation
|
GO:0043302 |
10 |
0.236
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.234
|
|
|
|
leukotriene metabolic process
|
GO:0006691 |
7 |
0.232
|
|
|
|
biological phase
|
GO:0044848 |
20 |
0.230
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.228
|
|
|
|
cerebellar granular layer development
|
GO:0021681 |
13 |
0.228
|
|
|
|
regulation of regulated secretory pathway
|
GO:1903305 |
20 |
0.226
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.225
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.223
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.221
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.221
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.221
|
|
|
|
cellular response to hydroperoxide
|
GO:0071447 |
4 |
0.219
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.217
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.214
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.213
|
|
|
|
positive regulation of mast cell activation
|
GO:0033005 |
12 |
0.211
|
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.210
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.208
|
|
|
|
cell cell junction maintenance
|
GO:0045217 |
3 |
0.206
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.206
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.205
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.202
|
|
|
|
negative regulation of metanephros development
|
GO:0072217 |
6 |
0.201
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.201
|
|
|
|
cellular response to erythropoietin
|
GO:0036018 |
1 |
0.198
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.195
|
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
37 |
0.194
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.193
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.190
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.190
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.187
|
|
|
|
positive regulation of renal albumin absorption
|
GO:2000534 |
1 |
0.187
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.185
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.184
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.182
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.182
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.180
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.179
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.178
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.174
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.174
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.173
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.172
|
|
|
|
interleukin 3 production
|
GO:0032632 |
3 |
0.171
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.171
|
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
15 |
0.169
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.169
|
|
|
|
toll like receptor 9 signaling pathway
|
GO:0034162 |
6 |
0.168
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.166
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.165
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.162
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.160
|
|
|
|
regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000583 |
2 |
0.160
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.158
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.158
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.156
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.155
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.155
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.155
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.154
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.154
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.152
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.151
|
|
|
|
glomerular visceral epithelial cell development
|
GO:0072015 |
6 |
0.151
|
|
|
|
positive regulation of hypersensitivity
|
GO:0002885 |
7 |
0.149
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.148
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.144
|
|
|
|
positive regulation of mast cell activation involved in immune response
|
GO:0033008 |
10 |
0.143
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.143
|
|
|
|
type ii hypersensitivity
|
GO:0002445 |
4 |
0.142
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.141
|
|
|
|
regulation of leukocyte degranulation
|
GO:0043300 |
20 |
0.141
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.138
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.136
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.136
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.136
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.135
|
|
|
|
negative regulation of kidney development
|
GO:0090185 |
15 |
0.134
|
|
|
|
regulation of macrophage differentiation
|
GO:0045649 |
9 |
0.133
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.132
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.132
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.131
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.131
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.131
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.131
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.129
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.129
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.128
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.128
|
|
|
|
positive regulation of metanephros development
|
GO:0072216 |
9 |
0.126
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.121
|
|
|
|
positive regulation of dendritic cell dendrite assembly
|
GO:2000549 |
1 |
0.121
|
|
|
|
immunoglobulin transcytosis in epithelial cells
|
GO:0002414 |
2 |
0.121
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.121
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.121
|
|
|
|
hypersensitivity
|
GO:0002524 |
10 |
0.121
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.120
|
|
|
|
detection of mechanical stimulus
|
GO:0050982 |
27 |
0.119
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.119
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.119
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.118
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.117
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.117
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.117
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.117
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.116
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.115
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.115
|
|
|
|
positive regulation of calcium mediated signaling
|
GO:0050850 |
15 |
0.114
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.113
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.113
|
|
|
|
regulation of mast cell degranulation
|
GO:0043304 |
16 |
0.113
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.113
|
|
|
|
adiponectin secretion
|
GO:0070162 |
2 |
0.112
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.110
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.110
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.109
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.109
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.107
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.106
|
|
|
|
regulation of adiponectin secretion
|
GO:0070163 |
2 |
0.106
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.106
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.106
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.106
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.105
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.104
|
|
|
|
cellular response to drug
|
GO:0035690 |
15 |
0.102
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.102
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.102
|
|
|
|
cell differentiation involved in metanephros development
|
GO:0072202 |
12 |
0.102
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.101
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.101
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.101
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.101
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.100
|
|
|
|
activation of jun kinase activity
|
GO:0007257 |
15 |
0.099
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.097
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.096
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.092
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.091
|
|
|
|
serotonin transport
|
GO:0006837 |
11 |
0.091
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.090
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.090
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.090
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.090
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.090
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.090
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.090
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.089
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.089
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.088
|
|
|
|
negative regulation of b cell differentiation
|
GO:0045578 |
4 |
0.088
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.088
|
|
|
|
positive regulation of immunoglobulin mediated immune response
|
GO:0002891 |
26 |
0.088
|
|
|
|
positive regulation of b cell receptor signaling pathway
|
GO:0050861 |
4 |
0.086
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.086
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.085
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.083
|
|
|
|
complement activation classical pathway
|
GO:0006958 |
2 |
0.083
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.082
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.081
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.081
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.081
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.081
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.081
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.081
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.080
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.080
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.080
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.079
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.078
|
|
|
|
positive regulation of b cell mediated immunity
|
GO:0002714 |
26 |
0.078
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.077
|
|
|
|
regulation of inflammatory response to antigenic stimulus
|
GO:0002861 |
21 |
0.077
|
|
|
|
melanocyte migration
|
GO:0097324 |
2 |
0.076
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.076
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.076
|
|
|
|
negative regulation of granulocyte differentiation
|
GO:0030853 |
3 |
0.076
|
|
|
|
cerebellar granular layer morphogenesis
|
GO:0021683 |
10 |
0.076
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.075
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.075
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.073
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.073
|
|
|
|
immune response inhibiting cell surface receptor signaling pathway
|
GO:0002767 |
3 |
0.072
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.072
|
|
|
|
regulation of metanephric glomerulus development
|
GO:0072298 |
5 |
0.072
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.072
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.071
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.071
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.070
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.070
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.070
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.070
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.070
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.070
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.069
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.069
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.069
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.069
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.068
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.067
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.067
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.066
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.066
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.065
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.065
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.065
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.065
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.064
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.064
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.063
|
|
|
|
regulation of calcium mediated signaling
|
GO:0050848 |
19 |
0.063
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.063
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.062
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.062
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.062
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.062
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.062
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.061
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.061
|
|
|
|
positive regulation of immunoglobulin production in mucosal tissue
|
GO:2000558 |
1 |
0.061
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.061
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.061
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.061
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.060
|
|
|
|
regulation of immunoglobulin production in mucosal tissue
|
GO:2000557 |
1 |
0.060
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.060
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.059
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.058
|
|
|
|
positive regulation of macrophage chemotaxis
|
GO:0010759 |
5 |
0.058
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.058
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.057
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.057
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.057
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.057
|
|
|
|
response to macrophage colony stimulating factor
|
GO:0036005 |
3 |
0.057
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.056
|
|
|
|
epithelial cell cell adhesion
|
GO:0090136 |
6 |
0.056
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.056
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.056
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.055
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.055
|
|
|
|
regulation of glucose import
|
GO:0046324 |
26 |
0.055
|
|
|
|
renal albumin absorption
|
GO:0097018 |
1 |
0.054
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.054
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.054
|
|
|
|
positive regulation of t helper 1 cell cytokine production
|
GO:2000556 |
1 |
0.054
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.053
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.053
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.053
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.053
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.053
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.052
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.052
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.052
|
|
|
|
regulation of natural killer cell chemotaxis
|
GO:2000501 |
1 |
0.052
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.052
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.051
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.051
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.051
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.051
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.050
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.050
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.050
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.050
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.050
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.049
|
|
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.049
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.049
|
|
|
|
positive regulation of acute inflammatory response to antigenic stimulus
|
GO:0002866 |
7 |
0.049
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.049
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.049
|
|
|
|
decidualization
|
GO:0046697 |
10 |
0.049
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.049
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.049
|
|
|
|
regulation of t helper 1 cell cytokine production
|
GO:2000554 |
1 |
0.049
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.048
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.048
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.048
|
|
|
|
glomerular epithelium development
|
GO:0072010 |
11 |
0.048
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.048
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.048
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.048
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.048
|
|
|
|
antigen processing and presentation of peptide antigen via mhc class ii
|
GO:0002495 |
17 |
0.048
|
|
|
|
positive regulation of podosome assembly
|
GO:0071803 |
3 |
0.048
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
18 |
0.048
|
|
|
|
granulocyte macrophage colony stimulating factor production
|
GO:0032604 |
3 |
0.047
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.047
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.047
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.047
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.047
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.046
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.046
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.046
|
|
|
|
negative regulation of macrophage differentiation
|
GO:0045650 |
4 |
0.046
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.045
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.045
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.045
|
|
|
|
g protein coupled purinergic nucleotide receptor signaling pathway
|
GO:0035589 |
1 |
0.045
|
|
|
|
regulation of actin cytoskeleton reorganization
|
GO:2000249 |
9 |
0.045
|
|
|
|
regulation of acute inflammatory response to antigenic stimulus
|
GO:0002864 |
10 |
0.045
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.045
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.045
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.044
|
|
|
|
acute inflammatory response to antigenic stimulus
|
GO:0002438 |
12 |
0.044
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class ii
|
GO:0019886 |
14 |
0.044
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.044
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.044
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.043
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.043
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.043
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.043
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.042
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.042
|
|
|
|
glomerular visceral epithelial cell differentiation
|
GO:0072112 |
10 |
0.042
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.042
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.042
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.042
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.041
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.041
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.041
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.041
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.041
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.041
|
|
|
|
ruffle organization
|
GO:0031529 |
16 |
0.041
|
|
|
|
memory
|
GO:0007613 |
58 |
0.041
|
|
